STKH:NASDAQSteakholder Foods Ltd. Analysis
Data as of 2026-05-03 - not real-time
$1.62
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Steakholder Foods (STKH) is trading at $1.62, well below its 20‑day SMA of $1.79 but above the 50‑day SMA of $1.52, indicating short‑term weakness despite a neutral longer‑term trend. The MACD histogram is negative and the signal line is bearish, while the RSI sits at 45, suggesting neither overbought nor oversold conditions. Volatility is extreme at 105% over the past 30 days, beta is 1.5, and the stock has endured a 96% max drawdown, underscoring substantial price instability.
The valuation metrics are stark: a price‑to‑book ratio of 405 and zero earnings, coupled with negative operating and free cash flow, point to severe overvaluation. The fear‑greed index reads “Extreme Greed,” reflecting speculative sentiment rather than fundamentals. High regulatory uncertainty for cultivated‑meat technologies and the company’s limited cash runway further amplify risk, while liquidity is thin given modest average volumes and a market cap of roughly $10 million.
The valuation metrics are stark: a price‑to‑book ratio of 405 and zero earnings, coupled with negative operating and free cash flow, point to severe overvaluation. The fear‑greed index reads “Extreme Greed,” reflecting speculative sentiment rather than fundamentals. High regulatory uncertainty for cultivated‑meat technologies and the company’s limited cash runway further amplify risk, while liquidity is thin given modest average volumes and a market cap of roughly $10 million.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish MACD and price below 20‑day SMA
- Extreme 30‑day volatility and high beta
- Support level at $1.42 being tested
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential upside from cultivated‑meat breakthroughs
- Continued cash burn and negative free cash flow
- Regulatory approval uncertainty
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term market opportunity in alternative proteins
- Current overvaluation and lack of earnings
- High execution risk and limited financial runway
Key Metrics & Analysis
Financial Health
ROE-179.04%
ROA-70.87%
P/B Ratio405.0
Op. Cash Flow$-6745000
Free Cash Flow$-4637625
Technical Analysis
TrendNeutral
RSI45.2
Support$1.42
Resistance$2.17
MA 20$1.79
MA 50$1.52
MA 200$3.42
MACDBearish
VolumeStable
Fear & Greed Index91.09
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.50
Volatility105.10%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.